1. Isobe, T., Naiki, T., Sugiyama, Y., Naiki-Ito, A., Nagai, T., Etani, T., Iida, K., Noda, Y., Shimizu, N., Aoki, M., Gonda, M., Morikawa, T., Banno, R., Kubota, H., Ando, R., Kawai, N., Yasui, T.: Experience and prognostic analysis with avelumab switch maintenance treatment in metastatic urothelial carcinoma. Oncology,103:11-21, 2025.
2. Ahmed, O.H.M., Naiki-Ito, A., Takahashi, S., Alexander, W.T., Alexander, D.B., Tsuda, H.: A review of the carcinogenic potential of thick rigid and thin flexible multi-walled carbon nanotubes in the lung. Nanomaterials, 15:168, 2025.
3. Yanase, T., Naiki, T., Naiki-Ito, A., Okawa, R., Niwa, S., Shimizu, N., Hamamoto, S., Fujii, Y., Takahashi, H., Yasui, T.: Efficacy of prostatectomy using a Retzius-sparing approach as an additional excision in anal canal carcinoma after brachytherapy for prostate adenocarcinoma. IJU Case Rep, 8:174-178, 2025
4. Naiki-Ito, A., Naiki, T., Takahashi, S.: Exploring experimental models of prostate cancer in chemoprevention: Oxidative stress as a key pathway to translational research. Pathol Int, 75:131-144, 2025.
5. Matsumoto, N., Wanifuchi-Endo Y., Fujita, T., Asano, T., Terada, M., Nozawa, K., Mori, M., Isogai, A., Niwa, Y., Kato, H., Komura, M., Toyama, T.: Prognosis, clinicopathological characteristics, and treatment patterns of patients with ER-intermediate-positive breast cancer undergoing long-term follow-up. ESMO Open, 10 :104508, 2025.
6. Naiki, T., Naiki-Ito, A., Murakami, A., Kato, H., Sugiyama, Y., Kawai, T., Kato, S., Etani, T., Nagai, T., Shimizu, N., Morikawa, T., Aoki, M., Gonda, M., Xiaochen, K., Nagayasu, Y., Hamamoto, S., Yasui, T., Takahashi, S.: Preliminary evidence on safety and clinical efficacy of luteolin for patients with prostate cancer under active surveillance. Prostate Cancer, in press.
7. Nukui, T., Shimura, T., Inaguma, S., Sugimura, N., Fukusada, S., Nishigaki, R., Kojima, Y., Kanno, T., Sasaki, M., Tanaka, M., Ozeki, K., Kubota, E., Takahashi, S., Kataoka, H.: Pathological resection depth in cold snare polypectomy and underwater endoscopic mucosal resection for superficial nonampullary duodenal epithelial tumors. Dig Dis, in press.
8. Wang, W., Kumegawa, K., Chapman, O., Shiraishi, R., Xiao, Z., Okonechnikov, K., Sun, Y., Pfister, S.M., Feng, W., Uesaka, N., Hoshino, M., Takahashi, S., Korshunov, A., Chavez, L., Maruyama, R., Kawauchi, D.: Chromatin modification abnormalities by CHD7 and KMT2C loss promote medulloblastoma progression. Cell Rep, in press.